These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27367867)

  • 1. Low Use of Oral Anticoagulant Prescribing for Secondary Stroke Prevention: Results From the Ontario Stroke Registry.
    Shah R; Li S; Stamplecoski M; Kapral MK
    Med Care; 2016 Oct; 54(10):907-12. PubMed ID: 27367867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reasons underlying non-adherence to and discontinuation of anticoagulation in secondary stroke prevention among patients with atrial fibrillation.
    Gumbinger C; Holstein T; Stock C; Rizos T; Horstmann S; Veltkamp R
    Eur Neurol; 2015; 73(3-4):184-91. PubMed ID: 25633474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China.
    Yang X; Li Z; Zhao X; Wang C; Liu L; Wang C; Pan Y; Li H; Wang D; Hart RG; Wang Y; Wang Y;
    Stroke; 2016 Feb; 47(2):464-70. PubMed ID: 26696643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing of oral anticoagulants in the emergency department and subsequent long-term use by older adults with atrial fibrillation.
    Atzema CL; Jackevicius CA; Chong A; Dorian P; Ivers NM; Parkash R; Austin PC
    CMAJ; 2019 Dec; 191(49):E1345-E1354. PubMed ID: 31818927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Anticoagulant Use at Nursing Home Admission and Variation by Frailty and Chronic Kidney Disease Among Older Adults with Atrial Fibrillation.
    Campitelli MA; Bronskill SE; Huang A; Maclagan LC; Atzema CL; Hogan DB; Lapane KL; Harris DA; Maxwell CJ
    Drugs Aging; 2021 Jul; 38(7):611-623. PubMed ID: 33880747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany - results from the German AFNET registry.
    Haeusler KG; Gerth A; Limbourg T; Tebbe U; Oeff M; Wegscheider K; Treszl A; Ravens U; Meinertz T; Kirchhof P; Breithardt G; Steinbeck G; Nabauer M;
    BMC Neurol; 2015 Aug; 15():129. PubMed ID: 26242880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.
    McGrath ER; Go AS; Chang Y; Borowsky LH; Fang MC; Reynolds K; Singer DE
    J Am Geriatr Soc; 2017 Feb; 65(2):241-248. PubMed ID: 28039855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA).
    Potpara TS; Larsen TB; Deharo JC; Rossvoll O; Dagres N; Todd D; Pison L; Proclemer A; Purefellner H; Blomström-Lundqvist C;
    Europace; 2015 Jun; 17(6):986-93. PubMed ID: 26023177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription frequency and predictors for the use of novel direct oral anticoagulants for secondary stroke prevention in the first year after their marketing in Europe--a multicentric evaluation.
    Luger S; Hohmann C; Kraft P; Halmer R; Gunreben I; Neumann-Haefelin T; Kleinschnitz C; Walter S; Haripyan V; Steinmetz H; Foerch C; Pfeilschifter W
    Int J Stroke; 2014 Jul; 9(5):569-75. PubMed ID: 24828272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
    Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
    Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
    Am J Cardiol; 2016 Jul; 118(2):210-4. PubMed ID: 27236255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
    Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
    J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in anticoagulant therapy prescription in patients with paroxysmal versus persistent atrial fibrillation.
    Hsu JC; Chan PS; Tang F; Maddox TM; Marcus GM
    Am J Med; 2015 Jun; 128(6):654.e1-654.e10. PubMed ID: 25554371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant Use in Patients With Nonvalvular Atrial Fibrillation: Has Prescribing Improved?
    Bista D; Chalmers L; Peterson GM; Bereznicki LRE
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):573-578. PubMed ID: 27071408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of secondary prevention medication and related factors for acute ischemic stroke and transient ischemic attack in China.
    Jiang Y; Yang X; Li Z; Pan Y; Wang Y; Wang Y; Ji R; Wang C
    Neurol Res; 2017 Jun; 39(6):492-497. PubMed ID: 28420316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary stroke prevention in atrial fibrillation: a challenge in the clinical practice.
    Tanislav C; Milde S; Schwartzkopff S; Sieweke N; Krämer HH; Juenemann M; Misselwitz B; Kaps M
    BMC Neurol; 2014 Sep; 14():195. PubMed ID: 25265943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment for the secondary prevention of stroke in older patients: the influence of dementia status.
    Moroney JT; Tseng CL; Paik MC; Mohr JP; Desmond DW
    J Am Geriatr Soc; 1999 Jul; 47(7):824-9. PubMed ID: 10404926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Anticoagulant Use in Atrial Fibrillation-Associated Ischemic Stroke: A Retrospective, Multicenter Survey in Northwestern China.
    Zhang J; Yang XA; Zhang Y; Wei JY; Yang F; Gao H; Jiao WW; Sun XL; Gao Q; Jiang W
    J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):125-131. PubMed ID: 27645612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM).
    Ansell J; Hollowell J; Pengo V; Martinez-Brotons F; Caro J; Drouet L
    J Thromb Thrombolysis; 2007 Apr; 23(2):83-91. PubMed ID: 17221328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.